510(k) Report

510(k) · Cleared

Recalled · Class II · 2016

Vitros Immunodiagnostics Products Estradiol Reagent Pack (Gem. 1050)/Estradiol Calibrators (Gem.C050)

K970643510(k) TraditionalCleared Mar 18, 199726-day reviewClass I21 CFR 862.1260Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Johnson & Johnson Clinical Diagnostics, Inc. · CHP Radioimmunoassay, Estradiol

Cleared on Mar 18, 1997 after a 26-day review. FDA lists a 510(k) statement for it but has not posted the file, so its predicates are not known. It has been recalled once.

Decided
Mar 18, 1997
Review
26 days
Class
Class I
Product code
CHP
Recalls
1
Predicates
0

FDA lists a 510(k) statement for it but has not posted the file, so its predicates are not known.

FIG. 1 — Lineage of K970643Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CHP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against?

FDA lists a 510(k) statement for it but has not posted the file, so its predicates are not known.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Jul 14, 2016Class IIZ-2352-2016Device DesignOrtho Clinical Diagnostics has issued a recall of their VITROS immunodiagnostics Estradiol Reagent assay. The firm was made aware of a potential cross-reactivity between the drug Fulvestrant and theVITROS Immunodiagnostic Estradiol…

No ancestor or descendant has a Class I recall.

How does its category compare?

All CHP devices

CHP Radioimmunoassay, Estradiol: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · CHP

FDA has decided no CHP device since 2007.

Median 510(k) review, days · CHP

Too few CHP 510(k)s in any year since 2007 to give a median.

Recalls per year · CHP

7in 2022

2007: 12010: 12016: 12017: 12018: 12021: 12022: 7
2007high 7 (2022) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · CHP

84in 2025

2008: 12009: 92010: 122011: 102012: 152013: 42014: 122015: 182016: 292017: 392018: 382019: 362020: 1352021: 432022: 612023: 602024: 652025: 84
2007high 135 (2020) · low 0 (2007)2025

MAUDE reports naming product code CHP, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—10
20080—01
20090—09
20100—112
20110—010
20120—015
20130—04
20140—012
20150—018
20160—129
20170—139
20180—138
20190—036
20200—0135
20210—143
20220—761
20230—060
20240—065
20250—084
20260—0—
Cite this page

510(k) Report. “K970643: Vitros Immunodiagnostics Products Estradiol Reagent Pack (Gem. 1050)/Estradiol Calibrators (Gem.C050).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K970643

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026